Pro MedicusASX:PME +3.58%98 PB Ratio is 49.82 as of Jun. 25, 2026, which is 11% below its 10-year median of 55.84. GuruFocus rates ASX:PME with a GF Score™ of 98/100 and a GF Value™ of A$244.95 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 611 Healthcare Providers & Services companies, Pro Medicus ranks worse than 99.18% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-06-25), Pro Medicus's share price is A$185.39. Pro Medicus's Book Value per Share for the quarter that ended in Dec. 2025 was A$3.72. Hence, Pro Medicus's PB Ratio of today is 49.82.
Good Sign:
Pro Medicus Ltd stock PB Ratio (=46.44) is close to 5-year low of 43.48.
The historical rank and industry rank for Pro Medicus's PB Ratio or its related term are showing as below:
ASX:PME'
s PB Ratio Range Over the Past 10 Years
Min: 14.54 Med: 55.84 Max: 158.96
Current: 49.82
During the past 13 years, Pro Medicus's highest PB Ratio was 158.96. The lowest was 14.54. And the median was 55.84.
ASX:PME's PB Ratio is ranked worse than 99.18% of 611
companies
in the Healthcare Providers & Services industry
Industry Median: 1.98
vs ASX:PME: 49.82
During the past 12 months, Pro Medicus's average Book Value Per Share Growth Rate was 74.90% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 36.10% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 33.20% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 26.50% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Pro Medicus was 48.00% per year. The lowest was -1.10% per year. And the median was 18.70% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Pro Medicus PB Ratio Related Terms
Pro Medicus PB Ratio Historical Data
* Premium members only.
The historical data trend for Pro Medicus's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Pro Medicus's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pro Medicus PB Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Pro Medicus's PB Ratio distribution charts can be found below:
* The bar in red indicates where Pro Medicus's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Pro Medicus's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Pro Medicus (ASX:PME) has a PB Ratio of 49.82 as of Jun. 25, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Pro Medicus and its competitors. This is 11% below median its historical median of 55.84. Over the past decade, Pro Medicus' PB Ratio has ranged from 14.54 to 158.96. According to the industry distribution chart, Pro Medicus ranks #606 out of 611 companies in the Healthcare Providers & Services industry, placing it in the top 99.2%.
Is Pro Medicus' PB Ratio too high?
Pro Medicus' current PB Ratio of 49.82 is 11% below median its 10-year median of 55.84. Over the past 10 years, this metric has ranged from a low of 14.54 to a high of 158.96. The Healthcare Providers & Services industry median PB Ratio is 1.98. Pro Medicus' value of 49.82 is 2416.2% above this industry median. Based on the distribution chart, Pro Medicus ranks #606 out of 611 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Pro Medicus has a GF Score™ of 98/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Pro Medicus' PB Ratio compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Pro Medicus ranks #606 out of 611 companies for PB Ratio. This places Pro Medicus in the lower half of its industry. The industry median PB Ratio is 1.98. Pro Medicus' value of 49.82 is 2416.2% above this benchmark. Historically, Pro Medicus' own PB Ratio has ranged from 14.54 to 158.96 over the past decade. While the company's 10-year median is 55.84 vs. the industry median of 1.98, Pro Medicus has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Healthcare Providers & Services company?
The median PB Ratio among Healthcare Providers & Services companies is 1.98, based on 611 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pro Medicus's current PB Ratio of 49.82 is 2416.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Pro Medicus and its competitors. For the Healthcare Providers & Services industry, the median PB Ratio is 1.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pro Medicus's current PB Ratio is 49.82, which is 11% below median its own 10-year median of 55.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pro Medicus stock overvalued right now?
Based on GuruFocus' analysis, Pro Medicus (ASX:PME) is currently considered Modestly Undervalued. The stock's GF Value™ is A$244.95, compared to a current price of A$185.39 — trading 24.3% below its estimated fair value. The current PB Ratio is 49.82, which is 11% below median its 10-year median of 55.84 and 2416.2% above the Healthcare Providers & Services industry median of 1.98. Pro Medicus' overall GF Score™ is 98/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Pro Medicus (ASX:PME), the current PB Ratio is 49.82 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pro Medicus (ASX:PME) Overvalued in 2026?
Based on GuruFocus' analysis, Pro Medicus stock appears to be undervalued.
The current stock price of A$185.39 is trading 24.3% below its estimated GF Value™ of A$244.95.
GuruFocus considers Pro Medicus to be Modestly Undervalued.
Key valuation signals for ASX:PME:
PB Ratio: 49.82 (11% below median its 10-year median of 55.84)
GF Value™: A$244.95 vs. price of A$185.39 (24.3% below fair value)
Industry Position: 2416.2% above the Healthcare Providers & Services median (#606 of 611)
No single metric tells the full story. See the ASX:PME stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pro Medicus is a healthcare IT company specializing in radiology imaging software. Its main product, Visage 7, is a clinical desktop application that radiologists use to view, enhance, and manipulate images from any device and make a diagnosis. Its main customers are US private academic hospitals. In fiscal 2025, Pro Medicus earned 90% of revenue in North America, 8% from Australia, and the remaining 2% in Europe.
98GF Score
Get the complete analysis for ASX:PME
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:PME has been successfully added to your 
